返回
Y
Yongkun Li
University of Science and Technology of China
19H指数
114论文数
1.1K被引数
收录论文 29
发表时间
A pomalidomide-based gefitinib PROTAC degrader effectively inhibits lung cancer progression in EGFR-TKIs-acquired resistant models by targeting EGFR degradation and ETFA-mediated ATP generation一种基于pomalidomide的gefitinib PROTAC降解剂通过靶向EGFR降解和ETFA介导的ATP生成,有效抑制了EGFR-TKIs获得性耐药模型中的肺癌进展。
Bioorganic Chemistry
IF4.7

